NO20072283L - Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme - Google Patents

Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme

Info

Publication number
NO20072283L
NO20072283L NO20072283A NO20072283A NO20072283L NO 20072283 L NO20072283 L NO 20072283L NO 20072283 A NO20072283 A NO 20072283A NO 20072283 A NO20072283 A NO 20072283A NO 20072283 L NO20072283 L NO 20072283L
Authority
NO
Norway
Prior art keywords
derivatives
piperazine
annealed
intermediates
preparing
Prior art date
Application number
NO20072283A
Other languages
English (en)
Inventor
Guenter Linz
Adil Duran
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35923724&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20072283(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20072283L publication Critical patent/NO20072283L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen omhandler en fremgangsmåte for fremstilling av annelerte piperazin-2-on derivater med generell formel (I), hvori restene R1 til R5, A1 og A2 har betydningene gitt i kravene og beskrivelsen, spesielt fremstillingen av 7,8-dihydro-5H-pteridin-6-on derivater. (I) ?? ?? ?? ?? 4
NO20072283A 2004-12-02 2007-05-03 Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme NO20072283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004058337A DE102004058337A1 (de) 2004-12-02 2004-12-02 Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
PCT/EP2005/056291 WO2006058876A1 (de) 2004-12-02 2005-11-29 Verfahren zur herstellung von annelierten piperazin-2-on derivaten sowie zwischenprodukte des verfahrens

Publications (1)

Publication Number Publication Date
NO20072283L true NO20072283L (no) 2007-06-28

Family

ID=35923724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072283A NO20072283L (no) 2004-12-02 2007-05-03 Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme

Country Status (35)

Country Link
US (9) US7238807B2 (no)
EP (2) EP1819706B1 (no)
JP (1) JP5164574B2 (no)
KR (2) KR101395591B1 (no)
CN (3) CN102093361B (no)
AR (1) AR053100A1 (no)
AU (1) AU2005311308B2 (no)
BR (1) BRPI0518601A2 (no)
CA (1) CA2588857C (no)
CL (1) CL2013002895A1 (no)
CY (1) CY1113625T1 (no)
DE (1) DE102004058337A1 (no)
DK (2) DK2436685T3 (no)
EA (1) EA012624B1 (no)
ES (2) ES2395829T3 (no)
HK (3) HK1113489A1 (no)
HR (1) HRP20120980T1 (no)
HU (1) HUE027689T2 (no)
IL (1) IL183568A (no)
ME (1) ME01470B (no)
MX (1) MX2007006549A (no)
MY (1) MY147459A (no)
NO (1) NO20072283L (no)
NZ (1) NZ556182A (no)
PE (2) PE20090488A1 (no)
PL (2) PL2436685T3 (no)
PT (1) PT1819706E (no)
RS (1) RS52533B (no)
SG (2) SG141461A1 (no)
SI (1) SI1819706T1 (no)
TW (1) TWI362391B (no)
UA (1) UA89390C2 (no)
UY (1) UY29233A1 (no)
WO (1) WO2006058876A1 (no)
ZA (1) ZA200703368B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
TW200804389A (en) 2006-02-14 2008-01-16 Vertex Pharma Dihydrodiazepines useful as inhibitors of protein kinases
JP4958461B2 (ja) * 2006-03-30 2012-06-20 富士フイルム株式会社 近赤外吸収色素含有硬化性組成物
MX2009008084A (es) 2007-02-01 2009-10-12 Astrazeneca Ab Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
WO2009019205A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
EP2100894A1 (en) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
CN102020643A (zh) 2009-09-22 2011-04-20 上海恒瑞医药有限公司 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
BR112012006652A2 (pt) * 2009-09-25 2015-09-08 Vertex Pharma métodos para preparar os derivados de pirimidina úteis como inibidores de proteína cinase
SG179207A1 (en) 2009-09-25 2012-04-27 Vertex Pharma Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
EP2678342B1 (en) 2011-02-25 2015-01-07 Takeda Pharmaceutical Company Limited N-substituted oxazinopteridines and oxazinopteridinones
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
UY34893A (es) 2012-07-10 2014-02-28 Takeda Pharmaceutical Derivados de azaindol
US20150031699A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
TW201620904A (zh) 2014-01-09 2016-06-16 武田藥品工業有限公司 氮雜吲哚衍生物
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032639A (en) * 1976-03-22 1977-06-28 American Home Products Corporation 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
US4182872A (en) * 1976-03-22 1980-01-08 American Home Products Corporation 4-(Lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acid chemical intermediates
NL8303657A (nl) 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
ES2058527T3 (es) 1988-06-16 1994-11-01 Smith Kline French Lab Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
FR2645152B1 (fr) * 1989-03-30 1991-05-31 Lipha 3h-pteridinones-4, procedes de preparation et medicaments les contenant
US5043270A (en) 1989-03-31 1991-08-27 The Board Of Trustees Of The Leland Stanford Junior University Intronic overexpression vectors
CA2029651C (en) 1989-11-17 2000-06-06 David D. Davey Tricyclic pteridinones and a process for their preparation
US5198547A (en) 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
TW274550B (no) * 1992-09-26 1996-04-21 Hoechst Ag
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
DE69611443T2 (de) * 1995-05-19 2001-07-12 Novartis Ag Verfahren zur katalytischen hydrogenierung von aromatischen nitroverbindungen
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
RS49597B (sr) 1996-09-23 2007-06-04 Eli Lilly And Company, Olanzapin dihidrat d
EE200100085A (et) * 1998-08-11 2002-08-15 Pfizer Products Inc. Asendatud 1,8-naftüridiin-4(1H)-oonid kui fosfodiesteraas 4 inhibiitorid
WO2001019825A1 (en) * 1999-09-15 2001-03-22 Warner-Lambert Company Pteridinones as kinase inhibitors
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
OA12227A (en) 2000-03-06 2004-03-18 Warner Lambert Co 5-AlkylpyridoÄ2,3-DÜpyrimidines tyrosine kinase inhibitors.
DE10018783A1 (de) 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2002076985A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6806272B2 (en) * 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
KR100955589B1 (ko) 2001-09-04 2010-04-30 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 신규한 디하이드로프테리디논, 이의 제조방법 및 이를 함유하는 약제학적 조성물
BRPI0117198B1 (pt) * 2001-12-14 2018-03-13 Merck Serono S.A. Usos de composição compreendendo um inibidor seletivo de uma isoforma 4 de fosfodiesterase
RS95404A (en) * 2002-05-03 2006-10-27 Schering Aktiengesellschaft Thiazolidinones and the use thereof as polo-like kinase inhibitors
KR20050071471A (ko) 2002-08-08 2005-07-07 스미스클라인 비참 코포레이션 티오펜 화합물
US6862422B2 (en) * 2003-02-12 2005-03-01 Kabushiki Kaisha Toshiba Image forming apparatus and image forming method having pressing members for pressing a belt-like member
NZ542498A (en) 2003-02-26 2009-01-31 Boehringer Ingelheim Pharma Dihydropteridinones, method for the production and use thereof in the form of drugs
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20040180898A1 (en) * 2003-03-03 2004-09-16 Bang-Chi Chen Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazines
JP2006523224A (ja) 2003-03-26 2006-10-12 ワイス 免疫原性組成物および方法
CA2522158C (en) 2003-04-14 2018-03-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
JP2007517828A (ja) * 2004-01-17 2007-07-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 気道の疾患を治療するための置換プテリジンの使用
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
DE102004034623A1 (de) * 2004-07-16 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2575804A1 (en) * 2004-08-26 2006-03-02 Boehringer Ingelheim International Gmbh Pteridinones used as plk (polo like kinase) inhibitors
EP1784406A1 (de) * 2004-08-27 2007-05-16 Boehringer Ingelheim International GmbH Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
WO2007014838A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Dihydropteridinones in the treatment of respiratory diseases
US7439358B2 (en) * 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
CN101437795A (zh) 2006-03-07 2009-05-20 阿斯利康(瑞典)有限公司 哌啶衍生物，制备它们的方法，它们作为治疗剂的用途和含有它们的药物组合物
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative

Also Published As

Publication number Publication date
IL183568A0 (en) 2007-09-20
ZA200703368B (en) 2008-09-25
ES2395829T3 (es) 2013-02-15
SI1819706T1 (sl) 2013-01-31
US7238807B2 (en) 2007-07-03
EP2436685B1 (de) 2015-07-01
SG141461A1 (en) 2008-04-28
CN101065381B (zh) 2011-03-30
CN102070637A (zh) 2011-05-25
US20070219369A1 (en) 2007-09-20
PL2436685T3 (pl) 2015-11-30
CN102070637B (zh) 2012-09-26
NZ556182A (en) 2009-08-28
DK2436685T3 (en) 2015-09-14
CN102093361A (zh) 2011-06-15
PE20090488A1 (es) 2009-05-27
CA2588857C (en) 2013-10-08
KR101362131B1 (ko) 2014-02-19
AU2005311308B2 (en) 2012-04-12
KR101395591B1 (ko) 2014-05-16
EP2436685A1 (de) 2012-04-04
EA012624B1 (ru) 2009-10-30
HK1158200A1 (en) 2012-07-13
BRPI0518601A2 (pt) 2008-11-25
KR20120136414A (ko) 2012-12-18
SG158848A1 (en) 2010-02-26
JP2008521861A (ja) 2008-06-26
PE20061061A1 (es) 2006-11-10
US20070213529A1 (en) 2007-09-13
US20070208027A1 (en) 2007-09-06
CA2588857A1 (en) 2006-06-08
MX2007006549A (es) 2007-06-18
IL183568A (en) 2015-02-26
UY29233A1 (es) 2006-07-31
DE102004058337A1 (de) 2006-06-14
ME01470B (me) 2014-04-20
MY147459A (en) 2012-12-14
HRP20120980T1 (hr) 2012-12-31
CL2013002895A1 (es) 2014-03-14
AR053100A1 (es) 2007-04-25
US20070213531A1 (en) 2007-09-13
ES2548680T3 (es) 2015-10-20
KR20070092252A (ko) 2007-09-12
AU2005311308A1 (en) 2006-06-08
US20070213528A1 (en) 2007-09-13
CN102093361B (zh) 2014-05-07
WO2006058876A1 (de) 2006-06-08
PT1819706E (pt) 2012-12-06
TW200628471A (en) 2006-08-16
EP1819706A1 (de) 2007-08-22
TWI362391B (en) 2012-04-21
US20070213534A1 (en) 2007-09-13
RS52533B (en) 2013-04-30
PL1819706T3 (pl) 2013-03-29
CN101065381A (zh) 2007-10-31
US20060122393A1 (en) 2006-06-08
EA200701164A1 (ru) 2007-12-28
EP1819706B1 (de) 2012-09-19
JP5164574B2 (ja) 2013-03-21
HUE027689T2 (hu) 2021-12-28
CY1113625T1 (el) 2016-06-22
USRE43115E1 (en) 2012-01-17
US7626019B2 (en) 2009-12-01
UA89390C2 (ru) 2010-01-25
HK1158199A1 (en) 2012-07-13
US20070213530A1 (en) 2007-09-13
DK1819706T3 (da) 2013-01-02
HK1113489A1 (en) 2008-10-03

Similar Documents

Publication Publication Date Title
NO20072283L (no) Fremgangsmate for fremstilling av annelerte piperazin-2-on derivater samt mellomprodukter i samme
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
TW200621779A (en) Process for the manufacture of dihydropteridinones
TW200640859A (en) Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
NO20044221L (no) Nye forbindelser
WO2006092213A8 (de) Pyrazolylcarboxanilide
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
WO2007031548A3 (en) Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
CO5690637A2 (es) Tiazol-(bi) cicloalquil-carboxanilidas
NO20070089L (no) DPP-IV inhibitorer
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
MXPA05011962A (es) Oxiarenos substituidos.
NO20061789L (no) Aminopyridinderivater som induserbare NO-syntaseinhibitorer
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
MXPA03010120A (es) Arilcetonas substituidas.
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
MX2007007554A (es) Oxiarenos sustituidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application